精神分裂症谱系障碍(SSD)与暴力之间的联系是大多数法医精神病服务的核心问题。然而,这些人口中暴力的驱动因素仍然不清楚,and,迄今为止,预测暴力风险的工具有一系列的局限性。也许是因为对暴力风险性质的这种不确定性,在整个欧盟,精神障碍罪犯的治疗方案和护理途径差异很大,法律和政策框架的差异是高度相关的。
为期三年的EU-VIORMED项目(批准号PP-2-3-2016,2017年11月至2020年10月)涉及意大利的法医中心,奥地利,德国,波兰,和英国它旨在:(a)识别和比较暴力风险因素,临床需求,使用病例对照设计对暴力(N=200,“病例”)和非暴力SSD患者(N=200;“对照”)的决策能力;(b)仅在病例(N=200)中测试HCR-20v3,OxMIS和FoVOx的预测有效性,使用前瞻性队列研究;(C)比较整个欧盟的法医-精神病学护理途径,在一项全大陆的服务制图研究中。
数据收集于2018年9月开始,并继续进行。到2019年9月,已经招募了333名参与者(招募了201例病例和132名对照)。来自23个国家的专家为服务制图工作提供数据。
2019年1月2日回顾性注册为researchregistry46042019年1月2日。
The link between schizophrenia spectrum disorders (SSD) and violence is a core issue for most forensic psychiatric services. However, the drivers of violence in this population remain unclear, and, to date tools to predict violence risk have a range of limitations. Perhaps because of this uncertainty about the nature of violence risk, treatment programmes and care pathways for mentally disordered offenders vary substantially across the European Union, and differences in legal and policy frameworks are highly relevant.
The three-year EU-VIORMED project (Grant Number PP-2-3-2016, November 2017-October 2020) involves forensic centres in Italy, Austria, Germany, Poland, and the U.K. It aims to: (a) identify and compare violence risk factors, clinical needs, and decision making capacity in violent (N = 200, \"cases\") and nonviolent patients with SSD (N = 200; \"controls\") using a case-control design; (b) test the predictive validity of the HCR-20v3, OxMIS and FoVOx among cases alone (N = 200), using a prospective cohort study; and (c) compare forensic-psychiatric care pathways across the EU, in a continent wide service mapping study.
Data collection started in September 2018 and continues. By September 2019, 333 participants have been enrolled (201 cases and 132 controls were recruited). Experts from 23 countries provided data for the service mapping exercise.
Retrospectively registered on January 2, 2019 as researchregistry4604 January 2, 2019.